About this event

  • Date and time Fri 24 Jan 2020 from 8:45am to 5:00pm
  • Location Royal Society of Medicine
  • Organised by Pain Medicine, Comparative Medicine

The meeting will review the pharmacological targets for pain management, and discuss the latest trends in chronic pain therapy, drawing on cross species knowledge and introducing the concept of the use of spontaneous disease models in animals to facilitate analgesic development in human medicine.

Topics includes:

  • Be updated on contemporary pharmacological management of chronic pain
  • Hear what’s likely to be the “next step” in the pharmacological management of chronic pain
  • Understand why new analgesic drug development can be slow and sometimes frustrating
  • Learn about a cross species approach to chronic pain management

This meeting is joint with the Association of Veterinary Anaesthetists (AVA). If you are an AVA member and wish to book on for this meeting there is a discount code available to you. This code can be accessed on the AVA website and can be found within the AVA digital newsletter.


Early bird pricing available until 31 August 2019.


RSM Fellow RSM Associate RSM Retired Fellow RSM Trainee RSM Student
£87.00 £45.00 £45.00 £45.00 £27.00

Non - Member

Consultant / GP AHP / Nurse / Midwife Trainee Student
£145.00 £75.00 £75.00 £45.00

Key speakers

Chas Bountra

Professor of Translational Medicine in the Nuffield Department of Clinical Medicine and Associate Member of the Department of Pharmacology at the University of Oxford

Speaker's biography

Chas is an invited expert on several government and charitable research funding bodies, and an advisor for many academic, biotech and pharma drug discovery programmes.

Chas was Vice President and Head of Biology at GlaxoSmithKline. He was involved in the identification of more than 40 clinical candidates for many gastro-intestinal, inflammatory and neuro-psychiatric diseases. More than 20 of these molecules progressed into patient studies and more than five of these delivered successful “Proof of Concept” data and hence progressed into late stage development. He was involved in the launch and development of the first treatment for Irritable Bowel Syndrome (Alosetron) and was the first to show that neurokinin NK1 antagonists are anti-emetic in preclinical and clinical studies.

Duncan Lascelles

Professor in Small Animal Surgery and Pain Management at North Carolina State University

Speaker's biography

At NC State University College of Veterinary Medicine, he organizes the Integrated Pain Management Service, and runs the Comparative Pain Research Program and is Associate Director of the Comparative Medicine Institute and Directs the Clinical Studies Core. 

He is board-certified in small animal surgery by the Royal College of Veterinary Surgeons, the European College of Veterinary Surgeons, and the American College of Veterinary Surgeons.  His research is focused on developing algometry methods in spontaneous disease animal models, and probing tissues from well-phenotyped animals with spontaneous disease to understand the neurobiology. The aim of his research is to improve pain control in companion animals and facilitate analgesic development in human medicine.

His work on pre-emptive analgesia, opioid use in cats, perioperative NSAIDs, outcome measures in canine OA and feline DJD has had significant impact on the way veterinary medicine is practiced.

Tony Dickenson

Professor of Neuropharmacology at University College, London

Speaker's biography

He has made seminal contributions to understanding the mechanisms of pain and how pain can be controlled in both normal and patho-physiological conditions and how to translate basic science to the patient. He has supervised 18 completed PhD students and makes a major contribution to undergraduate science and medical teaching. He is a founding and continuing member of the London Pain Consortium, a Wellcome Trust Integrated Physiology Initiative and now a Strategic Award, funding a group of scientists in London and Oxford studying pain mechanisms and training young scientists in integrated approaches to the study of pain from genes to function. He is training director of the programme. Prof. Dickenson was a member of the Council of the International Association for the Study of Pain for 6 years and is an associate editor for the journal Pain. He is a regular assessor of grant applications for the MRC, BBSRC, Wellcome Trust, Human Frontiers Programme and is a member of the research committee of INSERM, France.

He has been a member of the Medical Research Council Postgraduate Assessment Committee, the Brain Research Association National Committee, The International Association for the Study of Pain, Scientific Commission and the UK Pain Society Executive Committee as well as the Scientific commission of the European Federation of Pain Societies.

He has authored more than 250 refereed publications including Science and Nature, edited 3 books and written numerous chapters. He has made many media appearances including BBC1, 2 and Channel 4 and spoken at the Royal Institution.

Prof. Dickenson has given plenary lectures at the World Congress on Pain, the European Pain Congress, the US National Pain Forum and numerous Pain Societies including the ASEAN, American, Canadian, Belgium, Scandinavian, British, Thailand, Irish and the Australian Pain Societies and at many other international and national meetings. He also speaks to GPs, at hospices and to schools. He was elected into the Academy of Medical Sciences in 2007 and was made an Honorary Member of the British Pain Society in 2009 for ‘an outstanding contribution to the alleviation of pain through personal endeavour and through his work for the Society’.

Dr Kirsty Bannister

Principal Investigator and Lecturer, King’s College London

Speaker's biography

Dr Bannister graduated from UCL in 2003 with a BSc in Pharmacology (first class honours) before completing a Master of Research and subsequent PhD in Epigenetics at Imperial College London. In 2008 Kirsty began a post-doctoral placement back at UCL in the Neuropharmacology of Pain laboratory, investigating neural and pharmacological systems that sub-serve pain transmission and modulation in the spinal cord and brain. Kirsty joined King’s College London in the autumn of 2017 on a permanent basis as a Lecturer in Pharmacology and Principal Investigator. Her interests remain to investigate how pain can be controlled in both normal and pathological conditions, and how to translate basic science to the patient.

Praveen Anand

Professor of Clinical Neurology and Head, Centre for Clinical Translation, based at Hammersmith Hospital campus

Speaker's biography

His research focuses on pathophysiological and molecular mechanisms in human sensory neuropathies and chronic pain syndromes. Collaborations with colleagues and pharmaceutical companies are directed to projects which bridge the gap between pre-clinical developments and their successful clinical applications.  The translational approach has guided the recent success of 4 novel drugs from the laboratory to Phase II trials for chronic neuropathic pain and itch.  He has over 200 peer-reviewed publications in journals including Nature, Nature Medicine, Nature Genetics, Science and The Lancet.


View the programme

Registration, tea and coffee
Welcome and introduction

Session one


Chair: Ms Louise Clark, President, Pain Medicine Section, Royal Society of Medicine and Head of Anaesthesia, Davies Veterinary Specialists

Barriers to the development of new pharmacotherapies in chronic pain

Professor Chas Bountra, Professor of Translational Medicine, The Nuffield Department of Clinical Medicine, Associate Member of the Department of Pharmacology, University of Oxford

Developing new drugs for chronic neuropathic pain

Professor Praveen Anand, Professor of Clinical Neurology and Head, Centre for Clinical Translation, Hammersmith Hospital, Imperial College Healthcare NHS Trust

Tea and coffee break
Naturally occurring models of animal pain in translation research

Professor Duncan Lascelles, Professor in Small Animal Surgery and Analgesia, Associate Director of the Comparative Medicine Institute, North Carolina State University College of Veterinary Medicine

Neuronal basis for the transition from acute to chronic pain

Dr Shafaq Sikandar, Lecturer, Experimental Medicine and Rheumatology, William Harvey Research Institute, London

Panel discussion

Session two


Chair: To be confirmed

New drugs on the block - anti-NGF antibodies

Professor Tony Dickenson, Professor of Neuropharmacology, Department of Neuroscience, Physiology and Pharmacology, University College London

A new class of analgesics: EP4 receptor antibodies

Professor Duncan Lascelles

Tea and coffee break
Descending modulation: SNRIs, DNIC and clinical application

Dr Kirsty Bannister, Principal Investigator and Lecturer, King’s College London


Professor Tony Dickenson

Panel discussion

Professor Chas Bountra, Professor Praveen Anand, Professor Duncan Lascelles, Dr Shafaq Sikandar, Professor Tony Dickenson, Dr Kirsty Bannister

Concluding remarks
Close of meeting

Evaluation surveys will be sent via email and certificates of attendance can be found in the 'My Account' area on the RSM website


Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE, United Kingdom

Other events of interest

TEN01 Promo

Behaviour science for better outcomes in health and care services

Leading researchers and practitioners in behaviour science explore the importance of behavioural change to pave the way for a new era of digital health to deliver essential healthcare benefits.

  • Price £30 - £185
  • Location Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE, United Kingdom
Book Book
ONN01 Promo

Empathy in healthcare: Practice, teaching and design

This meeting will explore the latest evidence-based ways to practice, teach, and embed empathy within healthcare settings. Jointly organised by the Oxford Empathy Programme, delegates will learn about the role and importance of empathy in healthcare from current research, education, policy, practice and patient perspectives.

  • Price £35 - £142
  • Location Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE, United Kingdom
Book Book
GPN01 Promo

Forward view: Vision and eye health

This multidisciplinary conference will bring together a wealth of professionals and medical experts to discuss, engage and create positive strategies for the vision sector. The conference will encompass interactive workshops with tangible takeaways, present new research and updates for all involved in eye health and care.

  • Price £27 - £130
  • Location Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE, United Kingdom
Book Book
PNN01 Promo

Basic management for nurses and allied health professionals

Explore how to assess pain, understand how pain medications work and review advanced techniques such as epidurals, local anaesthetic infusions and patient-controlled analgesia.

  • Price £15 - £58
  • Location Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE, United Kingdom
Book Book